Michael Botticelli
http://dbpedia.org/resource/Michael_Botticelli an entity of type: Thing
Michael P. Botticelli (born January 2, 1958) is an American public health official who served as the director of the White House Office of National Drug Control Policy (ONDCP) from March 2014 until the end of President Obama's term. He was named acting director after the resignation of Gil Kerlikowske, and received confirmation from the United States Senate in February 2015. Prior to joining ONDCP, he worked in the Massachusetts Department of Public Health. Following completion of his service as ONDCP Director, he became the executive director of the Grayken Center for Addiction Medicine at the Boston Medical Center.
rdf:langString
Michael P. Botticelli (n. 2 de enero de 1958) es un funcionario público estadounidense, que entre otras cosas, se desempeñó como director de la Oficina de la Política Nacional para el Control de Drogas (ONDCP), desde marzo de 2014 hasta el final del mandato del presidente Obama, habiendo sido nombrado como director en funciones luego de la renuncia de , y recibiendo luego la confirmación del Senado de Estados Unidos en febrero de 2015. Antes de unirse a la White House Office of National Drug Control Policy (ONDCP), Botticelli trabajó en el .
rdf:langString
rdf:langString
Michael P. Botticelli
rdf:langString
Michael Botticelli
rdf:langString
Michael Botticelli
rdf:langString
Michael Botticelli
xsd:date
1958-01-02
xsd:integer
34570116
xsd:integer
1124660067
xsd:date
1958-01-02
xsd:date
2016-07-08
rdf:langString
Siena College
rdf:langString
St. Lawrence University
rdf:langString
rdf:langString
Director of the Office of National Drug Control Policy
rdf:langString
David Wells
xsd:gMonthDay
--03-07
xsd:date
2017-01-20
xsd:date
2014-03-07
rdf:langString
Director of the Office of National Drug Control Policy
xsd:integer
2014
rdf:langString
Michael P. Botticelli (n. 2 de enero de 1958) es un funcionario público estadounidense, que entre otras cosas, se desempeñó como director de la Oficina de la Política Nacional para el Control de Drogas (ONDCP), desde marzo de 2014 hasta el final del mandato del presidente Obama, habiendo sido nombrado como director en funciones luego de la renuncia de , y recibiendo luego la confirmación del Senado de Estados Unidos en febrero de 2015. Antes de unirse a la White House Office of National Drug Control Policy (ONDCP), Botticelli trabajó en el . Además, Michael Botticelli es el director ejecutivo del Centro Grayken para Medicina de Adicciones en el Boston Medical Center.
rdf:langString
Michael P. Botticelli (born January 2, 1958) is an American public health official who served as the director of the White House Office of National Drug Control Policy (ONDCP) from March 2014 until the end of President Obama's term. He was named acting director after the resignation of Gil Kerlikowske, and received confirmation from the United States Senate in February 2015. Prior to joining ONDCP, he worked in the Massachusetts Department of Public Health. Following completion of his service as ONDCP Director, he became the executive director of the Grayken Center for Addiction Medicine at the Boston Medical Center.
xsd:nonNegativeInteger
10815